News

AbbVie announced that the European Commission (EC) has approved the type-II variation application for VENCLYXTO (venetoclax) in combination with rituximab for the treatment of patients…
Read More...

Puration confirmed the developing joint venture agreement with Kali, Inc. and Nouveau Life Pharmaceuticals, Inc. to develop cannabis pharmaceutical products. Puration further confirms…
Read More...

As part of CoreRx, Inc's growth in expanding its cGMP manufacturing capabilities to support niche commercial products, we are pleased to announce the completed installation of the Optel…
Read More...

Avance Biosciences announced that its Houston facility was inspected by the U.S. Food and Drug Administration on October 01 through October 04, 2018.  This inspection focused on the…
Read More...

Genesis Biotechnology Group (GBG) and its CRO arm Genesis Drug Discovery & Development (GD3) announced today that it has entered into a partnership with Yale University to offer an…
Read More...

Distributed Bio announced a discovery collaboration with H3 Biomedicine, Inc. designed to help accelerate the discovery of novel cancer therapeutics. The collaboration will leverage…
Read More...

Novartis announced that it has entered into a clinical development agreement with Pfizer which will include a study combining tropifexor and one or more Pfizer compounds for the…
Read More...

AstraZeneca has agreed to divest the prescription medicine rights to Nexium (esomeprazole) in Europe, as well as the global rights (excluding the US and Japan) to Vimovo …
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has approved INVOKANA (canagliflozin) to reduce the risk of…
Read More...

Lonza announced the acquisition of a controlling stake in Octane Biotech, with the right to acquire full ownership. The increase in equity share will allow Lonza to further develop the…
Read More...

Bioasis Technologies announced it has entered into a licensing agreement with a subsidiary of Prothena Corporation plc) (“Prothena”), granting Prothena certain rights to use the xB3…
Read More...

Rigel Pharmaceuticals announced that it had entered into an exclusive license and supply agreement with Kissei Pharmaceutical Co., Ltd. ("Kissei") to develop and commercialize TAVALISSE…
Read More...

Eli Lilly and Company and Dicerna Pharmaceuticals announced a global licensing and research collaboration focused on the discovery, development and commercialization of potential new…
Read More...

Charles River Laboratories International announced that it has entered into an exclusive partnership with Distributed Bio, Inc., a leader in the computational design and optimization of…
Read More...

Alcami Corporation announced its collaboration with Medicines Development for Global Health (MDGH), a not-for-profit Australian biopharmaceutical company dedicated to the development of…
Read More...

Aerie Pharmaceuticals announced that it has built and commenced operation of its GMP (Good Manufacturing Practices)-validated manufacturing facility for production of ophthalmic…
Read More...

Thermo Fisher Scientific Inc. completed its previously announced acquisition of the Advanced Bioprocessing business from BD (Becton, Dickinson and Company – NYSE: BDX), a leading global…
Read More...

CannTrust Holdings continues to develop its reach and global footprint and announced today that it has entered into a strategic partnership with Australian licensed producer, Cannatrek…
Read More...

Johnson & Johnson unveiled a new, state-of-the-art vaccines launch facility that represents a significant investment by the company in novel vaccines development, global health and…
Read More...

Vetter is a leading solution provider of prefilled drug-delivery systems and a specialist for a wide range of packaging solutions. In addition to labelling, blister packing, cartoning…
Read More...